ANADYS
Anadys Pharmaceuticals is a biopharmaceutical company dedicated to developing medicines for the treatment of hepatitis C. The company is developing ANA598, a non-nucleoside polymerase inhibitor for the treatment of hepatitis C. Anadys has also investigated the potential of ANA773, an oral, small-molecule inducer of endogenous interferons that acts via the Toll-like receptor 7, or TLR7, pathway in hepatitis C.
ANADYS
Industry:
Biopharma Biotechnology Clinical Trials
Founded:
2000-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.anadyspharma.com
Total Employee:
11+
Status:
Active
Total Funding:
17.5 M USD
Technology used in webpage:
Polish Server Location
Similar Organizations
Acologix
Acologix is a biopharmaceutical company developing therapeutic compounds for the treatment of osteo-renal diseases.
Ansun BioPharma
Ansun BioPharma is a clinical-stage biopharmaceutical company focused on the development of host-directed anti-viral.
Arcus Biosciences
Arcus Biosciences is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer.
Arno Therapeutics
Arno Therapeutics is a biopharmaceutical company developing innovative products for the treatment of cancer patients.
Chiasma
Chiasma is a biopharmaceutical company developing oral drugs for the treatment of orphan diseases.
Endourage
Endourage is a pharmaceutical company that focuses on developing indication-specific therapeutics for clinical use.
Neurolixis
Neurolixis is a biopharmaceutical company that develops drugs for the treatment of central nervous system disorders.
OncoImmune
OncoImmune is a clinical-stage biopharmaceutical company that develops solutions for the treatment of cancer.
ReVision Therapeutics
ReVision Therapeutics, a biopharmaceutical company, develops drugs for the treatment of age-related macular degeneration diseases.
Seven and Eight Biopharmaceuticals
Seven and Eight Biopharmaceuticals is a biopharmaceutical company that develops proprietary novel immuno-oncology therapies.
Stock Details
Official Site Inspections
http://www.anadyspharma.com
- Host name: eris.hostido.net.pl
- IP address: 185.110.51.69
- Location: Poland
- Latitude: 52.2394
- Longitude: 21.0362
- Timezone: Europe/Warsaw